Inborn errors of development : the molecular basis of clinical disorders on morphogenesis /

Saved in:
Bibliographic Details
Imprint:New York : Oxford University Press, 2004.
Description:xxiv, 1082 p. : ill. (some col.) ; 29 cm.
Language:English
Series:Oxford monographs on medical genetics ; no. 49
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5056710
Hidden Bibliographic Details
Other authors / contributors:Epstein, Charles J.
Erickson, Robert P., 1939-
Wynshaw-Boris, Anthony Joseph.
ISBN:019514502X (cloth : alk. paper)
Notes:Includes bibliographical references and index.
Table of Contents:
  • Contributors
  • I. General Concepts
  • 1.. Human Malformations and Their Genetic Basis
  • 2.. General Principles of Differentiation and Morphogenesis
  • 3.. Model Organisms in the Study of Development and Disease
  • 4.. Consequences of the Genome Project for Understanding Development
  • II. Patterns of Development
  • 5.. Development Origins of the Mammalian Body Plan
  • 6.. Neural Crest Formation and Craniofacial Development
  • 7.. Development of the Nervous System
  • 8.. Development of the Ear
  • 9.. Development of the Heart and Vasculogenesis
  • 10.. Development of Muscle and Somites
  • 11.. Development of Bone and Cartilage
  • 12.. Development of the Limbs
  • 13.. Development of the Genitourinary System
  • 14.. Development of Endodermal Derivatives in the Lung, Liver, Pancreas, and Gut
  • 15.. Development of Epidermal Appendages: Teeth and Hair
  • III. Defined Pathways
  • Part A.. The Sonic Hedgehog Signaling Pathway
  • 16.. An Introduction to Sonic Hedgehog Signaling
  • 17.. DHCR7 and the Smith-Lemli-Opitz (RSH) Syndrome and Cyclopamine Teratogenesis
  • 18.. SHH and Holoprosencephaly
  • 19.. PTCH and the Basal Cell Nevus (Gorlin) Syndrome
  • 20.. GLI3 and the Pallister-Hall and Greig Cephalopolysyndactyly Syndromes
  • 21.. SALL1 and the Townes-Brocks Syndrome
  • Part B.. The Wnt (Wingless-Type) Signaling Pathway
  • 22.. Wnt Signaling Pathways
  • 23.. WISP3 and Progressive Pseudorheumatoid Dysplasia
  • Part C.. The Transforming Growth Factor [beta] (TGF-[beta]) Signaling Pathway
  • 24.. An Introduction to TGF-[beta]-Related Signaling
  • 25.. NOG and Proximal Symphalangisms, Multiple Synostosis Syndrome, Tarsal-Carpal Coalition, and Isolated Stapes Ankylosis
  • 26.. ZIC3, CFC1, ACVR2B, and EBAF and the Visceral Heterotaxies
  • 27.. CDMP1 and Chondrodysplasia (Grebe, Hunter-Thompson, and Du Pan Types) and Brachydactyly, Type C
  • 28.. ENG and ALK1 and Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome) and Vascular Morphogenesis
  • 29.. RUNX2 and Cleidocranial Dysplasia
  • Part D.. The Tumor Necrosis Factor Signaling Pathway
  • 30.. Signaling by TNF and Related Ligands
  • 31.. ED1, EDAR, and EDARADD and the Hypohidrotic Ectodermal Dysplasias and the Ectodysplasin Signaling Pathway
  • Part E.. The Fibroblast Growth Factor Signaling Pathway
  • 32.. Molecular and Cellular Biology of FGF Signaling
  • 33.. FGFs/FGFRs and Associated Disorders
  • 34.. TWIST and the Saethre-Chotzen Syndrome
  • Part F.. The Glial Cell-Derived Neurotrophic Factor Signaling Pathway
  • 35.. Signaling Pathways of Glial Cell-Derived Neurotrophic Factor
  • 36.. RET and Hirschsprung Disease and Multiple Endocrine Neoplasia Type 2
  • Part G.. The Endothelin Signaling Pathway
  • 37.. Introduction to Endothelin-3/Endothelin-B Receptor and SOX10 Signaling Pathways
  • 38.. EDNRB, EDN3, and SOX10 and the Shah-Waardenburg Syndrome
  • Part H.. The Notch Signaling Pathway
  • 39.. Introduction to Notch Signaling
  • 40.. JAG1 and the Alagille Syndrome
  • 41.. DLL3 and Spondylocostal Dysostosis
  • Part I.. The Sex Determination Pathway
  • 42.. Introduction to the Sex Determination Pathway: Mutations in Many Genes Lead to Sexual Ambiguity and Reversal
  • 43.. SOX9 and Campomelic Dysplasia and Sex Reversal
  • 44.. AMH/MIS and Its Receptors and Sexual Ambiguity and Persistent Mullerian Derivatives
  • 45.. DAX1 and X-Linked Adrenal Hypoplasia Congenita and XY Sex Reversal
  • IV. Gene Families Not Yet in Pathways
  • Part A.. The Homeobox Gene Family
  • 46.. The Role of Hox and Dlx Gene Clusters in Evolution and Development
  • 47.. HOXD13 and Synpolydactyly
  • 48.. HOXA13 and the Hand-Foot-Genital and Guttmacher Syndromes
  • 49.. Transcription Factors Involved in Disorders of Forebrain and Pituitary Development
  • 50.. IDX1 and Pancreatic Agenesis and Type 2 Diabetes
  • 51.. MSX1 and Partial Anodontia, Orofacial Clefting, and the Witkop Syndrome
  • 52.. MSX2 and ALX4 and Craniosynostosis and Defects in Skull Ossification
  • 53.. SHOX and Dyschondrosteosis and the Turner Syndrome
  • 54.. HLXB9 and Sacral Agenesis and the Currarino Syndrome
  • 55.. EYA1 and the Branchio-Oto-Renal Syndrome
  • 56.. PITX2 and PITX3 and the Axenfeld-Rieger Syndrome, Iridogoniodysgenesis and Iris Hypoplasia, Peters Anomaly, and Anterior Segment Ocular Dysgenesis
  • 57.. CSX/NKX2-5 and Congenital Heart Disease
  • 58.. LMX1B and the Nail Patella Syndrome
  • Part B.. The Paired-Box (PAX) Gene Pathway
  • 59.. Introduction to Paired-Box Genes
  • 60.. PAX2 and the Renal-Coloboma Syndrome
  • 61.. PAX3 and the Waardenburg Syndrome Type 1
  • 62.. PAX6 and Aniridia and Related Phenotypes
  • 63.. PAX9 and Hypodontia
  • Part C.. The Forkhead Gene Family
  • 64.. Introduction to Forkhead Genes
  • 65.. FOXC1 and FOXL2 and the Axenfeld-Rieger Malformations and the Blepharophomisis, Ptosis, and Epicanthus Inversus Syndrome
  • 66.. FOXC2 and Lymphedema Distichiasis
  • Part D.. The T-Box Gene Family
  • 67.. Introduction to the T-Box Genes and Their Roles in Developmental Signaling Pathways
  • 68.. TBX1 and the DiGeorge Syndrome Critical Region
  • 69.. TBX3 and TBX5 and the Ulnar-Mammary and Holt-Oram Syndromes
  • V. Processes
  • Part A.. Regulation of Chromatin Structure and Gene Expression
  • 70.. Mechanisms of Regulated Gene Transcription
  • 71.. CBP and the Rubinstein-Taybi Syndrome
  • 72.. ATRX and the X-Linked [alpha]-Thalassemia Mental Retardation Syndrome
  • 73.. IGF2, H19, p57[superscript KIP2], and LIT1 and the Beckwith-Wiedemann Syndrome
  • 74.. 15q11-13 and the Prader-Willi Syndrome
  • 75.. DNMT3B and the Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome
  • 76.. RSK2 and the Coffin-Lowry Syndrome
  • Part B.. Transcription Factors
  • 77.. MITF and the Waardenburg Type II and Albinism-Deafness (Tietz) Syndromes
  • 78.. POU3F4 and Mixed Deafness with Temporal Bone Defect (DFN3)
  • 79.. TFAP2B and the Char Syndrome
  • Part C.. Posttranslational Control and Ubiquination
  • 80.. An Introduction to Posttranslational Control by Ubiquitin-Dependent Proteolysis
  • 81.. UBE3A and the Angelman Syndrome
  • 82.. VHL and von Hippel-Lindau Disease
  • 83.. MKKS and the McKusick-Kaufman and Bardet-Biedl Syndromes
  • Part D.. Guanine Nucleotide-Binding Proteins
  • 84.. An Introduction to Guanine Nucleotide-Binding Proteins
  • 85.. GNAS and McCune-Albright Syndrome/Fibrous Dysplasia, Albright Hereditary Osteodystrophy/Pseudohypoparathyroidism Type IA, Progressive Osseous Heteroplasia, and Pseudohypoparathyroidism Type IB
  • 86.. FGD1 and Faciogenital Dysplasia (Aarskog-Scott Syndrome)
  • 87.. NF1 and Neurofibromatosis 1
  • Part E.. Kinases and Phosphatases
  • 88.. ROR2 and Brachydactyly Type B and Recessive Robinow Syndrome
  • 89.. PTPN11 and the Noonan Syndrome
  • Part F.. Microtubule Motors and Cytoskeleton
  • 90.. Microtubule Motors: Intracellular Transport, Cell Division, Ciliary Movement, and Nuclear Migration
  • 91.. TSC1 and TSC2 and Tuberous Sclerosis
  • 92.. LIS1 and DCX and Classical Lissencephaly
  • 93.. RELN and Lissencephaly with Cerebellar Hypoplasia
  • 94.. DNAI1 and DNAH5 and Primary Ciliary Dyskinesia or Kartagener Syndrome
  • Part G.. Extracellular Matrix
  • 95.. Extracellular Matrix and Signaling during Development
  • 96.. GPC3 and the Simpson-Golabi-Behmel Syndrome
  • 97.. HSPG2 (Perlecan) and the Schwartz-Jampel Syndrome and Dyssegmental Dysplasia, Silverman-Handmaker Type
  • 98.. L1CAM and X-Linked Hydrocephalus
  • 99.. COMP and Pseudoachondroplasia
  • 100.. MMP2 and the Multicentric Osteolysis with Nodulosis and Arthritis Syndrome
  • Part H.. Angiogenesis
  • 101.. Angiopoietins, TIEs, Ephrins, Vascular Endothelial Growth Factors, and Vascular Endothelial Growth Factor Receptors
  • 102.. VEGFR3 and Milroy Disease
  • Part I.. Transporters
  • 103.. KCNJ2 (Kir2.1) and Andersen Syndrome
  • 104.. ANKH and Craniometaphyseal Dysplasia
  • VI. Dysmorphic Disease Genes of Unknown Function
  • 105.. p63 and the Ectodermal Dysplasia, Ectrodactyly, and Cleft Lip and/or Palate (EEC), Limb-Mammary (LMS), Ankyloblepharon, Ectrodactyly, and Cleft Lip/Palate (AEC, Hay-Wells), and Acro-Dermato-Ungual-Lacrimal-Digit (ADULT) Syndromes and Ectrodactyly (Split Hand/Foot Malformation)
  • 106.. TCOF1 (Treacle) and the Treacher Collins Syndrome
  • 107.. LMBR1 and Acheiropodia and Preaxial Polydactyly
  • 108.. BBS Genes and the Bardet-Biedl Syndrome
  • Index